These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents' efficacy. Papacharalampous GX; Constantinidis J; Fotiadis G; Zhang N; Bachert C; Katotomichelakis M Int Forum Allergy Rhinol; 2024 Jan; 14(1):96-109. PubMed ID: 37394893 [TBL] [Abstract][Full Text] [Related]
6. Chinese Expert Consensus on the Use of Biologics in Patients with Chronic Rhinosinusitis (2022, Zhuhai). Hong HY; Chen TY; Yang QT; Sun YQ; Chen FH; Lou HF; Wang HT; Yu RL; An YF; Liu F; Wang TS; Lu MP; Qiu QH; Wang XD; Chen JJ; Meng CD; Xie ZH; Meng J; Zeng M; Xu CL; Wang Y; Yang YC; Zhang WT; Tang J; Yang YL; Xu R; Yu GD; Shi ZH; Wei X; Ye HP; Sun YN; Yu SQ; Zhang TH; Yong J; Hang W; Xu YT; Xu Y; Tan GL; Sun N; Yang G; Li YJ; Ye J; Zuo KJ; Zhang LQ; Wang XY; Yang AN; Xu YX; Liao W; Fan YP; Li HB ORL J Otorhinolaryngol Relat Spec; 2023; 85(3):128-140. PubMed ID: 37019094 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design. De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739 [TBL] [Abstract][Full Text] [Related]
8. Which Is the Best Biologic for Nasal Polyps: Dupilumab, Omalizumab, or Mepolizumab? A Network Meta-Analysis. Wu Q; Zhang Y; Kong W; Wang X; Yuan L; Zheng R; Qiu H; Huang X; Yang Q Int Arch Allergy Immunol; 2022; 183(3):279-288. PubMed ID: 34607329 [TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis. Oykhman P; Paramo FA; Bousquet J; Kennedy DW; Brignardello-Petersen R; Chu DK J Allergy Clin Immunol; 2022 Apr; 149(4):1286-1295. PubMed ID: 34543652 [TBL] [Abstract][Full Text] [Related]
10. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps. Patel GB; Peters AT Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps. Koski RR; Hill L; Taavola K J Pharm Technol; 2022 Oct; 38(5):289-296. PubMed ID: 36046351 [No Abstract] [Full Text] [Related]
12. Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps. Mullol J; Bachert C; Amin N; Desrosiers M; Hellings PW; Han JK; Jankowski R; Vodicka J; Gevaert P; Daizadeh N; Khan AH; Kamat S; Patel N; Graham NMH; Ruddy M; Staudinger H; Mannent LP J Allergy Clin Immunol Pract; 2022 Apr; 10(4):1086-1095.e5. PubMed ID: 34628065 [TBL] [Abstract][Full Text] [Related]
13. A comparative analysis of endoscopic sinus surgery versus biologics for treatment of chronic rhinosinusitis with nasal polyposis. Miglani A; Soler ZM; Smith TL; Mace JC; Schlosser RJ Int Forum Allergy Rhinol; 2023 Feb; 13(2):116-128. PubMed ID: 35980852 [TBL] [Abstract][Full Text] [Related]
14. The Role of Biologics in the Treatment of Nasal Polyps. Franzese CB Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452 [TBL] [Abstract][Full Text] [Related]
15. Adverse events of biological therapy in chronic rhinosinusitis with nasal polyps: A systematic review. Aldajani A; Alroqi A; Alromaih S; Aloulah MO; Alsaleh S Am J Otolaryngol; 2022; 43(6):103615. PubMed ID: 36057193 [TBL] [Abstract][Full Text] [Related]
16. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis. Chen S; Zhou A; Emmanuel B; Thomas K; Guiang H Curr Med Res Opin; 2020 Nov; 36(11):1897-1911. PubMed ID: 32847417 [TBL] [Abstract][Full Text] [Related]
17. Benefits of biologic therapy administered for asthma on co-existent chronic rhinosinusitis: A real-world study. Bajpai S; Marino MJ; Rank MA; Donaldson AM; O'Brien EK; Lal D Int Forum Allergy Rhinol; 2021 Aug; 11(8):1152-1161. PubMed ID: 33527730 [TBL] [Abstract][Full Text] [Related]
18. Biologics in Chronic Rhinosinusitis: Current and Emerging. Boyd JT; Khanwalkar AR Immunol Allergy Clin North Am; 2024 Nov; 44(4):657-671. PubMed ID: 39389716 [TBL] [Abstract][Full Text] [Related]
19. Biologic Therapy in Pediatric Chronic Rhinosinusitis: A Systematic Review. Rahavi-Ezabadi S; Zhou S; Lee SE; Ference E; Magit A; Leuin S; Mohamed K; Rezaei N; Patel VA Otolaryngol Head Neck Surg; 2024 Jul; 171(1):35-44. PubMed ID: 38488239 [TBL] [Abstract][Full Text] [Related]
20. Treatment options for chronic rhinosinusitis with nasal polyps. Wallace DV Allergy Asthma Proc; 2021 Nov; 42(6):450-460. PubMed ID: 34871152 [No Abstract] [Full Text] [Related] [Next] [New Search]